Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab

Carmine Pecoraro; Alfonso Ferretti; Erica Rurali; Miriam Galbusera; Marina Noris; Giuseppe Remuzzi

doi:10.1053/j.ajkd.2015.06.032

Related publications

Article2011

Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype

Luca A. Lotta, Haifeng Wu, Marie Scully, Marina Noris, Agnès Veyradier, Ian Mackie, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Roberta Palla, Flora Peyvandi

Article2009

Inherited thrombotic thrombocytopenic purpura

Miriam Galbusera, Marina Noris, Giuseppe Remuzzi

Article2012

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng Wu, Ian Mackie, Marina Noris, Agnès Veyradier, Marie Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi

Article2015

ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment

Erica Rurali, Federica Banterla, Roberta Donadelli, Elena Bresin, Miriam Galbusera, Sara Gastoldi, Flora Peyvandi, Mary Underwood, Giuseppe Remuzzi, Marina Noris

Article2023

Estimating the Population-Based Prevalence of Congenital Thrombotic Thrombocytopenic Purpura Using Large-Scale Sequencing Data

Omid Seidizadeh, Andrea Cairo, Ilaria Mancini, Pasquale Agosti, Frits R. Rosendaal, Flora Peyvandi

Blood